MedPath

施维雅(天津)制药有限公司

Ownership
-
Established
2000-07-03
Employees
-
Market Cap
-
Website
https://www.servier.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

NMPA:11

Drug Approvals

Tianeptine Sodium Tablets

Product Name
达体朗
Approval Number
国药准字H20033738
Approval Date
Jan 7, 2020
NMPA

Perindopril and Indapamide Tablets

Product Name
百普乐
Approval Number
国药准字H20051756
Approval Date
Dec 5, 2019
NMPA

Perindopril tert-Butylamine Tablets

Product Name
雅施达
Approval Number
国药准字H20034053
Approval Date
Dec 5, 2019
NMPA

Trimetazidine Hydrochloride Tablets

Product Name
万爽力
Approval Number
国药准字H20055465
Approval Date
Dec 5, 2019
NMPA

Perindopril and Indapamide Tablets

Product Name
百普乐
Approval Number
国药准字H20051755
Approval Date
Dec 5, 2019
NMPA

Perindopril tert-Butylamine Tablets

Product Name
雅施达
Approval Number
国药准字H20103382
Approval Date
Dec 5, 2019
NMPA

Trimetazidine Hydrochloride Modified Release Tablets

Product Name
盐酸曲美他嗪缓释片
Approval Number
国药准字H20100077
Approval Date
Dec 5, 2019
NMPA

lndapamide Sustained-release Tablets

Product Name
纳催离
Approval Number
国药准字H20031281
Approval Date
Dec 4, 2019
NMPA

Gliclazide Modified Release Tablets

Product Name
达美康
Approval Number
国药准字H20044694
Approval Date
Dec 4, 2019
NMPA

Citrus Bioflavonoids Tablets

Product Name
柑橘黄酮片
Approval Number
国药准字H20093975
Approval Date
May 20, 2019
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.